Skip to main content
Top
Published in: Rheumatology International 12/2013

01-12-2013 | Original Article

Evaluation of prognostic factors in medically treated patients of spinal tuberculosis

Authors: Ravindra Kumar Garg, Tushar Raut, Hardeep Singh Malhotra, Anit Parihar, Madhumati Goel, Amita Jain, Rajesh Verma, Maneesh Kumar Singh

Published in: Rheumatology International | Issue 12/2013

Login to get access

Abstract

This study was aimed to determine the prognostic factors in medically treated patients of spinal tuberculosis. In this longitudinal observational study, from July 2010 to December 2011, 70 consecutive patients (40 males and 30 females) spinal tuberculosis were enrolled. Diagnosis of spinal tuberculosis was based on characteristic clinical and neuroimaging features. Diagnosis was histopathologically and/or bacteriologically verified. Patients received antituberculous treatment as per World Health Organization guidelines and were followed for 6 months. Disability was evaluated with modified Barthel index (MBI). Outcome was defined as good (MBI > 12) and poor (MBI ≤ 12). Various clinical and neuroimaging parameters, likely to affect the outcome, were analyzed using univariate and multivariate analysis. After 6 months, 45 patients had a good outcome, while 25 patients had a poor outcome. On univariate analysis, duration of illness >6 months (OR 0.062, CI 0.018–0.212), bladder involvement (OR 0.102, CI 0.033–0.317), spinal deformity (OR 0.050, CI 0.013–0.196), spastic paraparesis (OR 0.572, CI 0.190–1.723), and flexor spasms (OR 0.077, CI 0.021–0.280) were found as important clinical predictors of poor outcome. Involvement of more than 2 vertebrae (OR 0.095, CI 0.028–0.328), complete collapse (OR 0.072, CI 0.022–0.241), cord compression (OR 0.025, CI 0.003–0.204), spinal extension of the abscess (OR 0.044, CI 0.005–0.350), and thick/septate abscess wall (OR 0.062, CI 0.016–0.240) were the neuroimaging parameters associated with poor prognosis. However, on multivariate analysis, duration of illness >6 months (Exp-b 0.086, CI 0.019–0.378), cord compression (Exp-b 0.035, CI 0.003–0348), and spinal extension of the abscess (Exp-b 0.109, CI 0.017–0.91) were significant. Medical management results in clinical improvement in a majority of the patients of spinal tuberculosis. Duration of illness >6 months, cord compression, and spinal extension of abscess are associated with poor outcome.
Literature
1.
go back to reference Jain AK, Kumar J (2013) Tuberculosis of spine: neurological deficit. Eur Spine J 22(Suppl 4):624–633PubMedCrossRef Jain AK, Kumar J (2013) Tuberculosis of spine: neurological deficit. Eur Spine J 22(Suppl 4):624–633PubMedCrossRef
2.
3.
go back to reference Jain AK (2010) Tuberculosis of the spine: a fresh look at an old disease. J Bone Joint Surg Br 92:905–913PubMed Jain AK (2010) Tuberculosis of the spine: a fresh look at an old disease. J Bone Joint Surg Br 92:905–913PubMed
4.
go back to reference Jain AK, Dhammi IK (2007) Tuberculosis of the spine: a review. Clin Orthop Relat Res 460(July):39–49PubMed Jain AK, Dhammi IK (2007) Tuberculosis of the spine: a review. Clin Orthop Relat Res 460(July):39–49PubMed
5.
go back to reference Park DW, Sohn JW, Kim EH, Cho DI, Lee JH, Kim KT et al (2007) Outcome and management of spinal tuberculosis according to the severity of disease: a retrospective study of 137 adult patients at Korean teaching hospitals. Spine (Phila Pa 1976) 32:E130–E135CrossRef Park DW, Sohn JW, Kim EH, Cho DI, Lee JH, Kim KT et al (2007) Outcome and management of spinal tuberculosis according to the severity of disease: a retrospective study of 137 adult patients at Korean teaching hospitals. Spine (Phila Pa 1976) 32:E130–E135CrossRef
6.
go back to reference Su SH, Tsai WC, Lin CY, Lin WR, Chen TC, Lu PL et al (2010) Clinical features and outcomes of spinal tuberculosis in southern Taiwan. J Microbiol Immunol Infect 43:291–300PubMedCrossRef Su SH, Tsai WC, Lin CY, Lin WR, Chen TC, Lu PL et al (2010) Clinical features and outcomes of spinal tuberculosis in southern Taiwan. J Microbiol Immunol Infect 43:291–300PubMedCrossRef
9.
go back to reference Colmenero JD, Ruiz-Mesa JD, Sanjuan-Jimenez R, Sobrino B, Morata P (2013) Establishing the diagnosis of tuberculous vertebral osteomyelitis. Eur Spine J 22(Suppl 4):S579–S586CrossRef Colmenero JD, Ruiz-Mesa JD, Sanjuan-Jimenez R, Sobrino B, Morata P (2013) Establishing the diagnosis of tuberculous vertebral osteomyelitis. Eur Spine J 22(Suppl 4):S579–S586CrossRef
10.
go back to reference Dunn R, Zondagh I, Candy S (2011) Spinal tuberculosis: magnetic resonance imaging and neurological impairment. Spine (Phila Pa1976) 36:469–473CrossRef Dunn R, Zondagh I, Candy S (2011) Spinal tuberculosis: magnetic resonance imaging and neurological impairment. Spine (Phila Pa1976) 36:469–473CrossRef
11.
go back to reference Moon MS, Moon YW, Moon JL, Kim SS, Sun DH (2002) Conservative treatment of tuberculosis of the lumbar and lumbosacral spine. Clin Orthop Relat Res 398(May):40–49PubMedCrossRef Moon MS, Moon YW, Moon JL, Kim SS, Sun DH (2002) Conservative treatment of tuberculosis of the lumbar and lumbosacral spine. Clin Orthop Relat Res 398(May):40–49PubMedCrossRef
12.
go back to reference Kumar R, Srivastava AK, Tiwari RK (2011) Surgical management of Pott’s disease of the spine in pediatric patients: a single surgeon’s experience of 8 years in a tertiary care center. J Pediatr Neurosci 6(Suppl 1):S101–S108PubMedCrossRef Kumar R, Srivastava AK, Tiwari RK (2011) Surgical management of Pott’s disease of the spine in pediatric patients: a single surgeon’s experience of 8 years in a tertiary care center. J Pediatr Neurosci 6(Suppl 1):S101–S108PubMedCrossRef
13.
go back to reference Jain AK, Jena A, Dhammi IK (2000) Correlation of clinical course with magnetic resonance imaging in tuberculous myelopathy. Neurol India 48:132–139PubMed Jain AK, Jena A, Dhammi IK (2000) Correlation of clinical course with magnetic resonance imaging in tuberculous myelopathy. Neurol India 48:132–139PubMed
14.
go back to reference van Loenhout-Rooyackers JH, Verbeek AL, Jutte PC (2002) Chemotherapeutic treatment for spinal tuberculosis. Int J Tuberc Lung Dis 6:259–265PubMed van Loenhout-Rooyackers JH, Verbeek AL, Jutte PC (2002) Chemotherapeutic treatment for spinal tuberculosis. Int J Tuberc Lung Dis 6:259–265PubMed
15.
go back to reference Jutte PC, Van Loenhout-Rooyackers JH (2006) Routine surgery in addition to chemotherapy for treating spinal tuberculosis. Cochrane Database Syst Rev (1):CD004532 Jutte PC, Van Loenhout-Rooyackers JH (2006) Routine surgery in addition to chemotherapy for treating spinal tuberculosis. Cochrane Database Syst Rev (1):CD004532
16.
go back to reference Colmenero JD, Ruiz-Mesa JD, Sanjuan-Jimenez R, Sobrino B, Morata P (2013) Establishing the diagnosis of tuberculous vertebral osteomyelitis. Eur Spine J 22(Suppl 4):579–586PubMedCrossRef Colmenero JD, Ruiz-Mesa JD, Sanjuan-Jimenez R, Sobrino B, Morata P (2013) Establishing the diagnosis of tuberculous vertebral osteomyelitis. Eur Spine J 22(Suppl 4):579–586PubMedCrossRef
Metadata
Title
Evaluation of prognostic factors in medically treated patients of spinal tuberculosis
Authors
Ravindra Kumar Garg
Tushar Raut
Hardeep Singh Malhotra
Anit Parihar
Madhumati Goel
Amita Jain
Rajesh Verma
Maneesh Kumar Singh
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 12/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2841-x

Other articles of this Issue 12/2013

Rheumatology International 12/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine